What happened
AriBioLab updated the terms of a private placement (third-party allotment) to raise US$3.34M, about 4.6% of its market value.
For context, this raise equals about 4.6% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Private placement |
|---|---|
| Raise amount | US$3.34M |
| vs. market value | 4.6% |
| Filed | 2026-05-29, [Amended] Material event report (rights offering) |
| Source | DART rcept 20260529001608 → open original filing |
Source: DART. Information only, not investment advice.